Back
Speaker illustration

Mr Eduardo Pons-Fuster Lopez

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

Presentations

Predictive capacity of the HFA-ICOS risk stratification scale for cardiovascular adverse events in patients treated with proteasome inhibitors

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Who is at risk of cardiovascular toxicity?

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources